Video

Managed Care Minute: March 7, 2015

A one-minute look at managed care news during the week of March 2, 2015, including oral arguments for King v. Burwell and the approval of the first biosimilar in the United States.

The Supreme Court of the United States heard oral arguments for King v. Burwell this week, and at the end of the hearing the justices were clearly divided about the legality of tax subsidies for consumers on the federally facilitated marketplace.

In oncology news, the US now has its first biosimilar with the FDA approval of Sandoz’s Zarxio for some cancer patients, plus the National Cancer Institute’s director is stepping down.

Finally, The American Journal of Managed Care convened a panel of experts to discuss the role of formulary management in the changing dynamics for hepatitis C. Listen to the panel discussion here.

Related Videos
Bridgette J. Picou, LVN, ACLPN, The Well Project
John Barkett, MBA
Emma Achola-Kothari, PhD
Dr Emma Achola-Kothani
Dr Emma Achola-Kothari
John Barkett, MBA
CK Wang, MD, COTA
John Barkett, MBA
Tom Belmont
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo